People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Other, Agriculture, Investment Vehicle, Agtech / Foodtech, Proptech / Real Estate, Consumer / Retail
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acreage FINCO B.C. Ltd. | — | Other | Series D+ | $167.2M | $2.9B | 2018 |
| Hazel Technologies, Inc. | — | Agriculture | Series C | $102.6M | $49.0M | 2023 |
| High Street Capital Partners, LLC | — | Investment Vehicle | Series C | $80.6M | $857.3M | 2017 |
| Hum Nutrition Inc. | — | Agtech / Foodtech | Series A | $22.2M | $144.9M | 2019 |
| Renew Residential, Inc. | — | Proptech / Real Estate | Series A | $21.9M | $38.4M | 2022 |
| Dixie Brands, Inc. | — | Consumer / Retail | Series A | $12.0M | $20.5M | 2014 |
| Luna Pharmaceuticals, Inc. | — | Biotech / Pharma | Series A | $10.5M | $148.6M | 2016 |
| Narragansett Brewing Co | — | Food & Beverage | Seed | $4.3M | $45.2M | 2020 |
| Corelink, Inc. | — | Other Technology | Pre-Seed | $1.0M | $42.4M | 2018 |
Kevin Murphy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Murphy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Melvin Yellin | 2 | 3 |
| Devin Binford | 2 | 2 |
| Glen Leibowitz | 2 | 2 |
| CHARLES SMITH | 1 | 14 |
| Matthew Walker | 1 | 11 |
| Patrick Flynn | 1 | 8 |
| Amy Wolf | 1 | 6 |
| Peter Finn | 1 | 5 |
| Carsten Boers | 1 | 5 |
| Brian McLaughlin | 1 | 4 |
| Phin Upham | 1 | 3 |
| George Allen | 1 | 3 |
| Benjamin Lee | 1 | 3 |
| Harlan Stone | 1 | 3 |
| Brian Graham | 1 | 3 |
| KEVIN M MURPHY | 1 | 3 |
| Robert Hayden | 1 | 3 |
| William Luby | 1 | 3 |
| Aditi Maliwal | 1 | 2 |
| Greg Richter | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.